THERESA GRIFFIN MARTIN: Open Payments
NPI 1952398232 · CANONSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 25 payments from 12 companies in 2025. Trend: 2023 $308 · 2024 $640 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Alkermes, Inc. | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| Lundbeck LLC | 2 | $52 |
| ABBVIE INC. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Corium, LLC | 2 | $19 |
Products named: ABILIFY MAINTENA, CAPLYTA, ARISTADA, INVEGA SUSTENNA, INGREZZA, VRAYLAR, UZEDY, Auvelity.
Industry payments across PA — which companies pay providers there.
